Are we underestimating health-tech?

There’s tourists. And then there’s the people who live in the place year round, whether it’s snowing, raining or the sun is shining bright. These people are the lifers. When it comes to health-tech, it appears that I am one of them.
Health-tech attracted lot of the tourist types in the heady years, back in 2020 and 2021. Around 2022, as we know from Rock Health data, it all started to stall out. Funding in the space by the end of 2023 was still significant - at $10.3 billion - but that represents the lowest amount of capital invested in the space since 2019.
The venture market is down for almost every category with the exception of AI, so that’s certainly a factor. But behind-the-scenes, I am also seeing a lot of generalist tech funds moving out of health care, either officially or unofficially (usually in the form of slowly reallocating resources and talent elsewhere). I have also examples of health care funds that can’t raise or have slowed down their pace of investing so they can focus on the existing portfolio. Please don’t ask me to name names. Because I won’t. But trust me that it is happening.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&
Peptide Therapy: Where Do We Go From Here?
Watch the full webinar Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management, metabolic health,
Not everyone can access the top 1% of physicians. Will AI change that?
Historically, top-tier medical expertise was limited by wealth and geography. As AI reshapes healthcare delivery, a vital question emerges: can it democratize intelligence to give everyone access to the caliber of care typically reserved for the top 1%?
Privacy AI and the Future of HIPAA
Watch the Full Webinar As AI reshapes healthcare and more patient data flows beyond traditional clinical settings, the rules governing privacy, access,
What will AI do for employer healthcare and benefits?
Employer healthcare may be one of the most practical — and overlooked — proving grounds for AI.
Hospitals as the new go-to-market, lessons from the trenches
Watch the Full Webinar Health systems are entering a new frontier, one where innovation isn’t optional, and meaningful change requires creativity,